Citius Pharmaceuticals (CTXR) Tax Rate (2022 - 2026)

Citius Pharmaceuticals (CTXR) has reported Tax Rate for 5 consecutive years, with 0.89% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Rate rose 385.0% year-over-year to 0.89%; the trailing twelve-month figure through Jun 2026 stood at 0.33% (up 195.0% YoY), and the FY2025 full-year result was 2.73%, down 125.0% from the prior year.
• Tax Rate improved to 0.89% in Q2 2026 per CTXR's latest filing, from 0.82% in the prior quarter.
• Across five years, Tax Rate topped out at 0.89% in Q2 2026 and bottomed at 4.17% in Q4 2022.
• Historically, Tax Rate has averaged 1.8% across 5 years, with a median of 1.71% in 2024.
• The sharpest annual moves came in 2025 and 2026: Tax Rate sank 180 bps in 2025, then surged 385 bps in 2026.
• Over 5 years, Tax Rate stood at 4.17% in 2022, then soared by 62 bps to 1.58% in 2023, then plunged by 66 bps to 2.64% in 2024, then retreated by 10 bps to 2.89% in 2025, then jumped by 131 bps to 0.89% in 2026.
• According to Business Quant data, Tax Rate over the past three periods registered 0.89%, 0.82%, and 2.89% for Q2 2026, Q1 2026, and Q4 2025 respectively.